In the UK, “compounded tirzepatide” is not an authorised generic equivalent of Mounjaro. UK law permits certain unlicensed medicines, known as “specials”, only under defined conditions for an individual patient’s special clinical needs. This is not a general route for mass-marketing copies or for selling research peptides. Products supplied as powder in vials that must be mixed before injection are not authorised GLP-1 presentations, according to the MHRA.
Mounjaro is licensed
The branded medicine has an MHRA marketing authorisation.
Specials are exceptional
Unlicensed supply is subject to strict individual-patient conditions.
Beware powder vials
The MHRA warns these are not authorised GLP-1 presentations.
Do not self-reconstitute
Do not inject research peptides or products from unverified sellers.
What “compounded” means in a UK context
The term “compounded tirzepatide” is often used in online material influenced by the United States. The UK regulatory framework is different. In the UK, an unlicensed medicine supplied as a “special” may be used only where the legal conditions are met, including an unsolicited order for an individual patient with a special clinical need and a prescriber who is directly responsible for that patient’s treatment.
The Human Medicines Regulations 2012, regulation 167, sets out an exemption from the usual marketing-authorisation requirement for qualifying special medicinal products. MHRA guidance explains the responsibilities of manufacturers, importers, distributors and suppliers. A “special” is not simply a cheaper copy of a licensed medicine and does not become equivalent to Mounjaro because it contains a substance described as tirzepatide.
Whether a particular unlicensed medicine is justified is a clinical and regulatory question. It should not be assumed that cost, convenience or a shortage automatically establishes a special clinical need. Patients should ask the prescriber and pharmacist to explain the product’s regulatory status, source, quality controls and why a licensed medicine is not suitable.
Why authorised product status matters
Mounjaro has an approved UK product information document setting out its composition, indications, dose schedule, warnings, storage conditions and device instructions. An unlicensed product may not have undergone the same assessment for quality, safety and efficacy as a medicine with a marketing authorisation. Its presentation, concentration, stability, sterility and instructions may differ.
The MHRA warns that GLP-1 medicines supplied as powder in vials that require mixing are not authorised presentations and pose significant health risks. Such products may be marketed as “research use only”, “peptides” or a low-cost alternative. They should not be treated as a legitimate patient medicine or injected after home reconstitution.
Do not assume that a product is safe because a website provides a certificate of analysis, a purity percentage or laboratory terminology. Those documents do not establish that a product is authorised, sterile, correctly formulated, appropriately stored or suitable for human injection.
Salt forms and claims about chemical equivalence
Online sellers may use terms such as sodium salt or acetate salt. Do not infer that a named salt form is equivalent to the active ingredient in the authorised medicine. Equivalence, bioavailability, stability and safety cannot be established from the name on a website or from a seller’s claim.
This article does not claim that every product advertised under these labels has been chemically tested or that a particular salt form has a specific clinical effect. The practical point is that an unverified peptide or salt product is not interchangeable with the authorised Mounjaro KwikPen. Do not purchase or inject it on the basis of an online description.
What patients should check
Use a registered pharmacy and a valid prescription. Ask which licensed product is being supplied, who is responsible for prescribing, where it is dispensed, and whether the product has a UK marketing authorisation. If a prescriber proposes an unlicensed special, ask why the licensed product cannot meet the patient’s individual clinical need and what additional uncertainties apply.
Avoid websites or social-media accounts selling vials, powders or “research peptides” for self-injection. If a product has already been purchased, do not reconstitute or inject it. Seek advice from a pharmacist or healthcare professional about safe disposal and what to do if it has already been used.
Frequently asked questions
Is compounded tirzepatide the same as Mounjaro?
No. A product described as compounded or as a special is not automatically equivalent to the authorised Mounjaro KwikPen. Its regulatory status and quality must be assessed separately.
Are UK “specials” legal?
Some unlicensed medicines can be supplied under strict legal conditions for an individual patient’s special clinical need. This is not a general permission for mass-market copies.
Are powder vials for mixing authorised Mounjaro presentations?
The MHRA says GLP-1 medicines supplied as powder in vials that must be mixed are not authorised presentations and pose significant risks.
Should I inject a research peptide labelled tirzepatide?
No. Do not inject unverified research products or self-reconstituted powders.
References
- 1.. MHRA. Supply unlicensed medicinal products (specials).
- 2.. The Human Medicines Regulations 2012, regulation 167.
- 3.. MHRA. GLP-1 medicines for weight loss and diabetes: what you need to know.
- 4.. General Medical Council. Remote prescribing: high-level principles.
- 5.. Electronic Medicines Compendium. Mounjaro KwikPen 5 mg: Summary of Product Characteristics (current UK product information).
Clinical and regulatory disclaimer
This article is for general educational information. It is not a diagnosis, an individual prescribing recommendation or a substitute for advice from a qualified healthcare professional. Product information and NHS commissioning arrangements can change; readers should check the linked official sources and discuss personal decisions with their prescriber or pharmacist. Vetted Therapeutics does not sell or supply medicines. In the UK, contact NHS 111 for urgent medical advice or 999 for a life-threatening emergency.